Liquid Biopsy in Non-Small Cell Lung Cancer

Liquid biopsy analyses are already incorporated in the routine clinical practice in many hospitals and oncology departments worldwide, improving the selection of treatments and monitoring of lung cancer patients. Although they have not yet reached its full potential, liquid biopsy-based tests will s...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in medicine 2016-12, Vol.3, p.69-69
Main Authors: Molina-Vila, Miguel A, Mayo-de-Las-Casas, Clara, Giménez-Capitán, Ana, Jordana-Ariza, Núria, Garzón, Mónica, Balada, Ariadna, Villatoro, Sergi, Teixidó, Cristina, García-Peláez, Beatriz, Aguado, Cristina, Catalán, María José, Campos, Raquel, Pérez-Rosado, Ana, Bertran-Alamillo, Jordi, Martínez-Bueno, Alejandro, Gil, María-de-Los-Llanos, González-Cao, María, González, Xavier, Morales-Espinosa, Daniela, Viteri, Santiago, Karachaliou, Niki, Rosell, Rafael
Format: Article
Language:English
Subjects:
Medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Liquid biopsy analyses are already incorporated in the routine clinical practice in many hospitals and oncology departments worldwide, improving the selection of treatments and monitoring of lung cancer patients. Although they have not yet reached its full potential, liquid biopsy-based tests will soon be as widespread as "standard" biopsies and imaging techniques, offering invaluable diagnostic, prognostic, and predictive information. This review summarizes the techniques available for the isolation and analysis of circulating free DNA and RNA, exosomes, tumor-educated platelets, and circulating tumor cells from the blood of cancer patients, presents the methodological challenges associated with each of these materials, and discusses the clinical applications of liquid biopsy testing in lung cancer.
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2016.00069